Australia's Neurotech International slips to a month low on discounted placement
04/08/2026 02:25
BUZZ-Australia's Neurotech International slips to a month low on discounted placement ** Shares of Australia's Neurotech International NTI.AX fall as much as 6.3% to A$0.015, their lowest level since July 3
** Stock hits biggest intraday pct drop since July 17
** Biopharma co says it would raise A$4.5 million ($3.15 million) through placement
** Offer price of A$0.014/share represents a 6.7% discount as of the co's last close on July 30, before it went into a trading halt for the placement announcement
** Says funds raised to fund co's phase III clinical trial of NTI164 in children with Autism Spectrum Disorder (ASD), including others
** YTD, stock up 7.1%
($1 = 1.4292 Australian dollars)
(Reporting by Aamir Sheik Khalid in Bengaluru)
Recent news on Neurotech International
See all newsBrief: Neurotech International Says Anthony Filippis Resigns As CEO, MD
Brief: Neurotech International Appoints Mark Davies As Executive Chairman
Brief: Neurotech International Receives Binding Commitments For Around A$4.50 Million In Placement At A$0.014 Per Share
Australia's Neurotech International slips to a month low on discounted placement
Brief: Neurotech International Requests Trading Halt